Glioblastoma, a highly aggressive form of brain cancer, remains an incurable disease despite advancements in medical treatment. While doctors can use surgery, radiation, and chemotherapy to extend the lives of patients, the prognosis is bleak—half of all patients succumb to the disease within a year of diagnosis. This has driven neuro-oncologists to search urgently for new drugs capable of targeting brain tumors more effectively. One of the major challenges in treating brain tumors like glioblastoma is the difficulty of finding drugs that can cross the blood-brain barrier. This natural defense…